Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers ; volume:16 ; number:2 ; day:23 ; month:4 ; year:2014 ; pages:1-14 ; date:4.2014
Arthritis Research & Therapy ; 16, Heft 2 (23.4.2014), 1-14, 4.2014
- Urheber
- Beteiligte Personen und Organisationen
-
Chighizola, Cecilia Beatrice
Rovelli, Francesca
Gerosa, Maria
SpringerLink (Online service)
- DOI
-
10.1186/ar4549
- URN
-
urn:nbn:de:1111-2016051825665
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Meroni, Pier Luigi
- Chighizola, Cecilia Beatrice
- Rovelli, Francesca
- Gerosa, Maria
- SpringerLink (Online service)
Ähnliche Objekte (12)
Recurrent non-stroke central neurologic manifestations in primary antiphospholipid syndrome
Antiphospholipid syndrome: a case report with an unusual wide spectrum of clinical manifestations
Current concepts in the diagnosis and management of antiphospholipid syndrome and ocular manifestations
Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort study
Antiphospholipid-Syndrom – Präeklampsie und antiphospholipid-Antikörper
Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19
Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome
Autoantibodies against galectin-2 peptides as biomarkers for the antiphospholipid syndrome
Primary antiphospholipid syndrome presenting as antiphospholipid syndrome nephropathy: a case report
The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study
Pathogenese des Antiphospholipid Syndroms
Hughes syndrome : antiphospholipid syndrome
Recurrent non-stroke central neurologic manifestations in primary antiphospholipid syndrome
Antiphospholipid syndrome: a case report with an unusual wide spectrum of clinical manifestations
Current concepts in the diagnosis and management of antiphospholipid syndrome and ocular manifestations
Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort study
Antiphospholipid-Syndrom – Präeklampsie und antiphospholipid-Antikörper
Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19
Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome
Autoantibodies against galectin-2 peptides as biomarkers for the antiphospholipid syndrome
Primary antiphospholipid syndrome presenting as antiphospholipid syndrome nephropathy: a case report
The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study
Pathogenese des Antiphospholipid Syndroms
Hughes syndrome : antiphospholipid syndrome
Recurrent non-stroke central neurologic manifestations in primary antiphospholipid syndrome
Antiphospholipid syndrome: a case report with an unusual wide spectrum of clinical manifestations
Current concepts in the diagnosis and management of antiphospholipid syndrome and ocular manifestations
Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort study
Antiphospholipid-Syndrom – Präeklampsie und antiphospholipid-Antikörper
Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19
Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome
Autoantibodies against galectin-2 peptides as biomarkers for the antiphospholipid syndrome
Primary antiphospholipid syndrome presenting as antiphospholipid syndrome nephropathy: a case report
The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study
Pathogenese des Antiphospholipid Syndroms